Skip to main content
. 2024 Feb 24;130(8):1269–1278. doi: 10.1038/s41416-024-02604-y

Fig. 3. Kaplan–Meier OS curves in the KRAS WT subgroup.

Fig. 3

Kaplan–Meier overall survival curves for KRAS wild-type subgroup of patients treated with EGFR mAb + chemo/BSC versus chemo/BSC alone. EGFR epidermal growth factor receptor.